b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30476990</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>09</Month>\n            <Day>16</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>09</Month>\n            <Day>16</Day>\n        </DateRevised>\n        <Article PubModel="Print">\n            <Journal>\n                <ISSN IssnType="Electronic">1945-1997</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>118</Volume>\n                    <Issue>12</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>Dec</Month>\n                        <Day>01</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>The Journal of the American Osteopathic Association</Title>\n                <ISOAbbreviation>J Am Osteopath Assoc</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Utility of 4-Factor Prothrombin Complex Concentrate in Trauma and Acute-Care Surgical Patients.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>789-797</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.7556/jaoa.2018.171</ELocationID>\n            <Abstract>\n                <AbstractText Label="Context" NlmCategory="UNASSIGNED">Since 2013, prothrombin complex concentrate (PCCs) have been approved in the United States for the reversal of anticoagulation induced by vitamin K antagonists. However, there has been limited investigation into their use in trauma and acute-care surgery (ACS).</AbstractText>\n                <AbstractText Label="Objective" NlmCategory="UNASSIGNED">To investigate the role that 4-factor PCC may have in reversing anticoagulation in the setting of trauma and ACS.</AbstractText>\n                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">All trauma and ACS patients who presented between March 14, 2014, and August 1, 2015, were included in this retrospective descriptive analysis. Patients receiving 4-factor PCC were compared with patients receiving fresh frozen plasma (FFP) alone. The following data were collected from medical records: age, sex, race, international normalized ratio (INR) at admission (baseline) and after reversal, blood products given, dosing of medication, injury severity score, length of stay, thromboembolic event, death during admission, and death within 90 days after admission.</AbstractText>\n                <AbstractText Label="Results" NlmCategory="UNASSIGNED">There were 188 trauma and ACS patients who required reversal of anticoagulation. Of these, 98 patients received FFP and 90 received PCC. Patients who received PCC were at increased risk for death during admission (20% vs 9.2% for FFP group) or within 90 days (39% vs 15%, respectively). Patients in the PCC group had a higher median baseline INR (2.9 vs 2.5 in the FFP group) and a lower postintervention INR (1.4 vs 1.8); consequently, the decrease in INR was greater in the PCC group than in the FFP group (1.5 vs 0.7, respectively). The number of total units of packed red blood cells transfused was significantly higher in patients receiving PCC.</AbstractText>\n                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">Patients receiving PCC had worse outcomes than those who received FFP. Given that these differences may have resulted from baseline differences between groups, these results mandate further prospective analysis of the use of PCC in trauma and ACS patients.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Sellers</LastName>\n                    <ForeName>William</ForeName>\n                    <Initials>W</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bendas</LastName>\n                    <ForeName>Charles</ForeName>\n                    <Initials>C</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Toy</LastName>\n                    <ForeName>Frederick</ForeName>\n                    <Initials>F</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Klock</LastName>\n                    <ForeName>Brian</ForeName>\n                    <Initials>B</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kerestes</LastName>\n                    <ForeName>Jamie</ForeName>\n                    <Initials>J</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Young</LastName>\n                    <ForeName>Amanda</ForeName>\n                    <Initials>A</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Badger</LastName>\n                    <ForeName>Clint</ForeName>\n                    <Initials>C</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Jensen</LastName>\n                    <ForeName>Jason</ForeName>\n                    <Initials>J</Initials>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Becker</LastName>\n                    <ForeName>Natasha</ForeName>\n                    <Initials>N</Initials>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>J Am Osteopath Assoc</MedlineTA>\n            <NlmUniqueID>7503065</NlmUniqueID>\n            <ISSNLinking>0098-6151</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D001779">Blood Coagulation Factors</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>12001-79-5</RegistryNumber>\n                <NameOfSubstance UI="D014812">Vitamin K</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>37224-63-8</RegistryNumber>\n                <NameOfSubstance UI="C025667">prothrombin complex concentrates</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001778" MajorTopicYN="N">Blood Coagulation Disorders</DescriptorName>\n                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>\n                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001779" MajorTopicYN="N">Blood Coagulation Factors</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName>\n                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>\n                <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019934" MajorTopicYN="N">International Normalized Ratio</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010949" MajorTopicYN="N">Plasma</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014812" MajorTopicYN="N">Vitamin K</DescriptorName>\n                <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName>\n                <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>\n                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>\n                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>27</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>27</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>9</Month>\n                <Day>17</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30476990</ArticleId>\n            <ArticleId IdType="pii">2716920</ArticleId>\n            <ArticleId IdType="doi">10.7556/jaoa.2018.171</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'